Zai Lab (ZLAB) Inventory (2018 - 2026)
Zai Lab (ZLAB) posted Inventory of $86.0 million for Q1 2026, up 15.01% sequentially from $74.7 million in Q4 2025, and up 62.03% YoY from $53.1 million in Q1 2025.
Analysis
Zai Lab (ZLAB) Inventory (2018 - 2026) Analysis & Trends
Zai Lab has reported Inventory for 9 years, with the latest figure at $86.0 million in Q1 2026.
- Quarterly Inventory rose 62.03% year-over-year to $86.0 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $86.0 million (up 62.03% YoY) and the FY2025 annual result came in at $74.7 million, up 87.45% from the prior year.
- Inventory climbed to $86.0 million in Q1 2026 per ZLAB's latest filing, from $74.7 million in the prior quarter.
- Over five years, Inventory peaked at $86.0 million in Q1 2026 and troughed at $20.3 million in Q1 2022.
- A 5-year average of $45.3 million and a median of $39.9 million in 2024 frame the typical range for Inventory.
- The sharpest annual moves came in 2022 and 2024: Inventory jumped 133.16% in 2022, then declined 11.05% in 2024.
- Over 5 years, Inventory stood at $31.6 million in 2022, then soared by 41.76% to $44.8 million in 2023, then retreated by 11.05% to $39.9 million in 2024, then surged by 87.45% to $74.7 million in 2025, then increased by 15.01% to $86.0 million in 2026.
- According to Business Quant data, Inventory over the past three periods registered $86.0 million, $74.7 million, and $67.1 million for Q1 2026, Q4 2025, and Q3 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Inventory (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn | 1.77 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn | 3.08 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn | 371.00 Mn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn | 280.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn | 732.60 Mn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn | 97.11 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn | 142.38 Mn |
| 10 | Zai Lab | 2.94 Bn | 2.23 Bn | 58.15 Mn | 90.89 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 90.89 Mn |
| Mar 31, 2026 | 85.96 Mn |
| Dec 31, 2025 | 74.75 Mn |
| Sep 30, 2025 | 67.14 Mn |
| Jun 30, 2025 | 61.70 Mn |
| Mar 31, 2025 | 53.05 Mn |
| Dec 31, 2024 | 39.88 Mn |
| Sep 30, 2024 | 39.55 Mn |
| Jun 30, 2024 | 41.85 Mn |
| Mar 31, 2024 | 37.85 Mn |
| Dec 31, 2023 | 44.83 Mn |
| Sep 30, 2023 | 44.23 Mn |
| Jun 30, 2023 | 36.35 Mn |
| Mar 31, 2023 | 38.41 Mn |
| Dec 31, 2022 | 31.62 Mn |
| Sep 30, 2022 | 29.13 Mn |
| Jun 30, 2022 | 23.34 Mn |
| Mar 31, 2022 | 20.29 Mn |
| Dec 31, 2021 | 19.00 Mn |
| Sep 30, 2021 | 12.49 Mn |